CALL US:022-2204 0015 / 16 / 17   isa@saffronmedia.in
HOME NEWS INGREDIENT MART EVENTS TOPICS INTERVIEW EDIT
 
News
 
A Raju, Hyderabad September 19 , 2020
With many pharmaceutical companies in the field of active pharmaceutical ingredient manufacturing seeking land for setting their bases in the newly developing Pharma City region, very soon Hyderabad is going to become the leading API manufacturing hub of India.  

With the central government granting the national investment manufacturing zone status to Hyderabad Pharma City, the Telangana government is now going ahead with its plans to allot land to as many as 150 pharmaceutical companies in the first phase.

Earlier, out of the total earmarked extent of over 19,000 acres of Pharma City land, the Telangana State Industries and Infrastructure Corporation (TSIIC) has already taken over 8,500 acres and developed roads, drains, common effluent plants, established power lines and other necessary infrastructure needed for the pharmaceutical companies.

According to officials from the industries department of Telangana, as many as 350 firms have approached the government seeking land in the Pharma City. Of them, the officials have decided to allot land to 150 firms in the first phase. “We are about to complete the first phase of Pharma City project in the next few days. Already a couple of API manufacturing, research and formulation based pharma companies have been allotted lands and work for setting up of their units is in the process. The TSIIC has also completed more than 95 per cent of works under the first phase and very soon by end of this year we are planning to operationalise the first phase of the Pharma City,” informed Jayesh Ranjan, Principal Secretary, Industries.

Recently, the Saptagir Labs, an API manufacturing company based in Hyderabad, had also expressed its intention to set up its unit in the Pharma City project and had even revealed that it had applied to the state government for the allotment of the land. As already Saptagir Labs has invested Rs. 75 crore in its WHO GMP certified pharmaceutical plant located at Chegunta in Medhcal.  The firm is now planning to accomplish its dream of becoming a US FDA certified firm by setting up its most advanced API manufacturing unit at Pharma City.

“We have already submitted an application to the industries department for allotment of land in Pharma City. We are targeting to achieve a manufacturing capacity of 500 kiloliter in the coming 2-3 years and planning to set out a strong footage as a leading API exporter from Hyderabad,” informed Shilpa Reddy, promoter and managing director of Saptagir Labs.

Share This Story

Leave a Reply
Your name (required)   Your email (required)
         
Website (required)
   
CommenT
 
Enter Code (Required)

 

 

 
INGREDIENT MART

RECENT NEWS

TOPICS
The healthy snacks segment is estimated to be around 2 per cent of the overall snacks market in India, according to expe ...

 

MAIN LINKS OUR SERVICES OTHER PRODUCTS ONLINE MEDIA  
 
About Us
Contact Us
News Archives
 

Product Finder
Features and Articles
News
 
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
 
Media Information
Rate Card
Advertise
 
 
Copyright © 2013 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Internet Explorer(9.0) or Firefox(26.0)